Health Care & Life Sciences » Pharmaceuticals | Marksans Pharma Ltd.

Marksans Pharma Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
719
1,094
1,069
155
-
Depreciation, Depletion & Amortization
157
161
281
301
-
Other Funds
-
23
-
-
-
Funds from Operations
812
1,288
1,215
359
626
Changes in Working Capital
260
203
881
241
-
Net Operating Cash Flow
552
1,491
334
118
-
Capital Expenditures
52
365
1,319
277
-
Net Investing Cash Flow
52
365
1,319
277
-
Cash Dividends Paid - Total
104
70
180
145
-
Issuance/Reduction of Debt, Net
85
999
335
219
-
Net Financing Cash Flow
189
257
515
58
-
Net Change in Cash
311
1,383
1,500
101
-
Free Cash Flow
500
1,126
985
160
-
Deferred Taxes & Investment Tax Credit
3
9
-
-
-
Change in Capital Stock
-
1,302
-
15
-

About Marksans Pharma

View Profile
Address
11th Floor Grandeur
Mumbai Maharashtra 400053
India
Employees -
Website http://www.marksanspharma.com
Updated 09/14/2018
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio spreads over major therapeutic areas such as oncology, gastroenterology, anti-diabetic, cardiovascular, pain management, and gynecology. The company was founded by Mark Saldanha on April 16, 1992 and is headquartered in Mumbai, India.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.